The Department is very proud to announce that Michael Imperiale, Arthur F. Thurnau Professor of Microbiology & Immunology, has been tapped to be the inaugural Associate Vice President of Research - Research Policy and Compliance, effective July 1, 2017. As AVP, Dr. Imperiale will lead the development and review of research policy and will serve as the key point of contact for research compliance. He will also oversee issues surrounding responsible conduct of research and will serve as the institutional research integrity officer.
Dr. Imperiale earned his BA and PhD from Columbia University in New York and subsequently completed a postdoctoral fellowship at The Rockefeller University before joining the University of Michigan as an Assistant Professor in 1984. His research has focused on virus replication, virus-host cell interactions and science policy. His current research focuses on the human pathogen BK polyomavirus (BKPyV), which infects the urinary tract in nearly 100% of the human population. While it doesn't cause disease in healthy individuals, in immunocompromised patients, replication of the virus can cause severe disease. There are currently no effective drugs with which to treat these infections. The Imperiale Lab is working toward understanding the viral and cellular factors that control BKPyV replication with the ultimate aim of identifying possible new targets for therapeutic intervention.
Dr. Imperiale is a Fellow of the American Academy of Microbiology and a Fellow of the American Association for the Advancement of Science, and has been awarded numerous honors, including a Distinguished Faculty Achievement Award, Endowment for the Basic Sciences Teaching Award, Rackham Distinguished Graduate Mentor Award and induction into the League of Educational Excellence, University of Michigan Medical School.
Dr. Imperiale has also been active in administration, holding a variety of leadership positions across campus, including Associate Chair for the Department of Microbiology & Immunology since 2007, Director of the Cellular Biotechnology Training Program, Director of the Cancer Biology Training Program, and Chair of the U-M Institutional Biosafety Committee. He has also been active in the science policy community, having served on the National Science Advisory Board for Biosecurity (a presidentially commissioned advisory board under the auspices of the DHHS), and on various policy-related committees of the National Research Council and National Academies.
We are very proud of Dr. Imperiale's accomplishments and fully support him in this new, vital role!